The latest confirmation likely reflects follow-up testing of a San Francisco child whose exposure to the virus is still under investigation.
Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe, and the 90 ...
Yesterday, the European Centre for Disease Control (ECDC) published an overview of imported mpox clade 1 cases in the ...
A hunter-harvested mule deer in the Hog Heaven Management Zone of Montana's Flathead Indian Reservation was confirmed ...
H.C. Wainwright analyst Ed Arce reiterated a Buy rating on Acurx Pharmaceuticals (ACXP – Research Report) today and set a price target of ...
C. difficile has been identified by the Centers for Disease Control and Prevention (CDC) as an urgent public health threat, contributing to more than 80 American deaths each day. LPOXY also plans ...
Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...
Pfizer advances second-generation C. diff vaccine with Phase 2 data expected in 2025. Analyst maintains cautious optimism as investor sentiment remains muted on vaccine efforts. Pfizer hosted a ...
Recurrence rates are also high. According to the Centers for Disease Control and Prevention (CDC), about 1 in 6 people with C. diff get a repeat infection within 2 to 8 weeks. The rates of ...
Looking for the scoop on types of poop? It may not be a topic of daily conversation, but your bowel movements can tell you ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...